Takis is delighted to announce that the event "Genetic vaccines: the future for infectious diseases and cancer" was a great success. A number of researchers from different Italian Research Institutions (ENEA, ISS), Pharmaceutical companies (Sigma-Tau, Dompè, Diatech), Assobiotec and students from Italy and Greece attended the presentations and contributed to an interesting debate on these emerging technologies.

"We are glad to be part of this initiative promoted by Assobiotec in Italy, which integrates our Takis Education Initiative. We look forward to joining again European Biotech Week next year" - commented Luigi Aurisicchio, CEO/CSO at Takis Biotech.